Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

ALGS Aligos Therapeutics Inc

13,05

-0,43 (-3,19%)

08 Mär 2025 - Geschlossen

Verzögert um 15 Minuten

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Article too big to display. Click here to view on the SEC website

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
Von Feb 2025 bis Mär 2025

Click Here for more Aligos Therapeutics Charts.

Aligos Therapeutics (NASDAQ:ALGS)
Historical Stock Chart
Von Mär 2024 bis Mär 2025

Click Here for more Aligos Therapeutics Charts.

News Aligos Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 4 März 2025 (4 Tage vor) • Edgar (US Regulatory)

Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025
Montag 3 März 2025 (6 Tage vor) • GlobeNewswire Inc.

Form D - Notice of Exempt Offering of Securities
Freitag 28 Februar 2025 (1 Woche vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 12 Februar 2025 (4 Wochen vor) • Edgar (US Regulatory)

Aligos Therapeutics Announces $105 Million Private Placement Financing
Mittwoch 12 Februar 2025 (4 Wochen vor) • GlobeNewswire Inc.

Form 8-K - Current report
Montag 3 Februar 2025 (1 Monat vor) • Edgar (US Regulatory)

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 13 Dezember 2024 (3 Monate vor) • GlobeNewswire Inc.

Aligos Therapeutics to Present at Investor Conferences in December
Dienstag 26 November 2024 (3 Monate vor) • GlobeNewswire Inc.

Aligos Therapeutics Presents Positive Data at The Liver Meeting (TLM) 2024
Dienstag 19 November 2024 (4 Monate vor) • GlobeNewswire Inc.

Form S-3 - Registration statement under Securities Act of 1933
Mittwoch 6 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 6 November 2024 (4 Monate vor) • Edgar (US Regulatory)

Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results
Mittwoch 6 November 2024 (4 Monate vor) • GlobeNewswire Inc.

Weitere Aligos Therapeutics Inc News-Artikel

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen